biologic blockbusters
Areteia Therapeutics Posts Phase 3 Win for Oral Asthma Drug Dexpramipexole
Areteia Therapeutics; dexpramipexole; Phase 3; oral asthma therapy; biologic blockbusters; eosinophilic asthma; EXHALE-4; topline results
Actionable Insights Powered by AI
Areteia Therapeutics; dexpramipexole; Phase 3; oral asthma therapy; biologic blockbusters; eosinophilic asthma; EXHALE-4; topline results